bitop and Yuria-Pharm enter a partnership and launch Ectoin® inhalation solution in the Ukraine.
bitop and Yuria-Pharm enter a partnership and launch Ectoin® inhalation solution in the Ukraine.
Dortmund, February 17th 2021
We are very happy to announce that our partner Yuria-Pharm, based in Kiev, has launched Ectoin® Inhalation Solution under the brand name ECTOBREATH® in the Ukrainian market.
The Ectoin® Inhalation Solution has been developed by bitop to reduce inflammations of the airways in case of pulmonary diseases such as bronchitis, asthma, or chronic obstructive pulmonary disease (COPD). Containing the 100% natural ingredient Ectoin® the solution has clinically shown superior reduction in bronchitis symptoms compared to traditional saline solutions*.
“The demand we see for our inflammation reducing inhalation solutions has never been as strong as today. People understand, that protecting lungs and airways is a good way to stay healthy. We are very glad to have entered a new market with our new partner Yuria-Pharm in this important indication”, states bitop CEO Wolfgang Hansen.
As manufacturer and distributor of a wide range of pharmaceuticals and medical products, Yuria-Pharm has a particularly strong footage in hospitals and healthcare facilities (HLF) in the Ukraine and started the distribution in their home market in early 2021.
About Ectoin® containing OTC-products
For more than ten years, bitop has developed and registered medical devices with Ectoin® and out-licensed these patent-protected products in a full-service model to partners all over the world. The natural protection molecule Ectoin® is made in Germany and provides a 100% natural mode of action. bitop offers products with Ectoin® with clinically proven claims in the categories of Cough&Cold, Allergy, Pulmonary Diseases, Ophthalmology, Dermatology and Supportive Cancer Treatment.
For more information on the product range, please contact info@bitop.de or visit www.bitop.de or contact our sales team directly under bd@bitop.de.
*Tran et al. 2019. Ectoine-Containing Inhalation Solution versus Saline Inhalation Solution in the Treatment of Acute Bronchitis and Acute Respiratory Infections: A Prospective, Controlled, Observational Study. BioMed Res Intern, Article ID 7945091.
